Author: Wu JJ1, Zhang YX1, Du WS1, Jiang LD2, Jin RF1, Yu HY1, Liu JM3, Han M4
1The Third Affiliated Hospital of Beijing University of Chinese Medicine.
2Dongzhimen Hospital Beijing University of Chinese Medicine.
3Dongfang Hospital Beijing University of Chinese Medicine.
4Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Conference/Journal: Medicine (Baltimore).
Date published: 2019 May
Other: Volume ID: 98 , Issue ID: 22 , Pages: e15776 , Special Notes: doi: 10.1097/MD.0000000000015776. , Word Count: 225
OBJECTIVE: To explore the clinical efficacy and safety of Qigong in reducing the self-rating depression scale (SDS) and self-rating anxiety scale (SAS) scores of patients with chronic obstructive pulmonary disease (COPD).
METHODS: We searched CNKI, Wan fang, Chongqing VIP, China Biology Medicine disc, PubMed, Cochrane Library, and EMBASE for studies published as of Dec 31, 2018. All randomized controlled trials of Qigong in COPD patients, which met the inclusion criteria were included. The Cochrane bias risk assessment tool was used for literature evaluation. RevMan 5.3 software was used for meta-analysis.
RESULTS: Six studies (combined n = 415 patients) met the inclusion criteria. Compared with conventional therapy alone, Qigong in combination with conventional therapy significantly improved the following outcome measures: SDS score [mean difference (MD) -3.99, 95% CI (-6.17, -1.82), P < .001, I = 69%]; SAS score[MD -4.57, 95% CI (-5.67, -3.48), P < .001, I = 15%]; forced expiratory volume in one second/prediction (FEV1% pred) [MD 3.77, 95% CI (0.97,6.58), P < .01, I = 0]; forced expiratory volume in one second (FEV1) [MD 0.21, 95% CI (0.13, 0.30), P < .001, I = 0%]; forced vital capacity (FVC) [MD 0.28, 95% CI (0.16, 0.40), P < .001, I = 0]; 6-minute walk test (6MWT) distance [MD 39.31, 95% CI (18.27, 60.34), P < .001, I = 32%]; and St. George's Respiratory Questionnaire (SGRQ) total score [MD -11.42, 95% CI (-21.80, -1.03), P < .05, I = 72%].
CONCLUSION: Qigong can improve the SDS and SAS scores of COPD patients, and has auxiliary effects on improving lung function, 6MWT distance, and SGRQ score.
PMID: 31145299 DOI: 10.1097/MD.0000000000015776